These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23935482)

  • 1. A multi-targeted drug candidate with dual anti-HIV and anti-HSV activity.
    Balzarini J; Andrei G; Balestra E; Huskens D; Vanpouille C; Introini A; Zicari S; Liekens S; Snoeck R; Holý A; Perno CF; Margolis L; Schols D
    PLoS Pathog; 2013; 9(7):e1003456. PubMed ID: 23935482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase.
    Andrei G; Gillemot S; Topalis D; Snoeck R
    J Infect Dis; 2018 Feb; 217(5):790-801. PubMed ID: 29186456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservation of antiviral activity and improved selectivity in PMEO-DAPym upon pyrimidine to triazine scaffold hopping.
    de Castro S; Fernández-Cureses G; Andrei G; Snoeck R; Sánchez-Murcia PA; Korba B; Gago F; Balzarini J; Camarasa MJ
    Antiviral Res; 2015 Oct; 122():64-8. PubMed ID: 26275802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex virus isolates with reduced adefovir susceptibility selected in vivo by foscarnet therapy.
    Bestman-Smith J; Boivin G
    J Med Virol; 2002 May; 67(1):88-91. PubMed ID: 11920821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pronounced in vitro and in vivo antiretroviral activity of 5-substituted 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy] pyrimidines.
    Balzarini J; Schols D; Van Laethem K; De Clercq E; Hocková D; Masojidkova M; Holý A
    J Antimicrob Chemother; 2007 Jan; 59(1):80-6. PubMed ID: 17124193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication.
    Andrei G; Lisco A; Vanpouille C; Introini A; Balestra E; van den Oord J; Cihlar T; Perno CF; Snoeck R; Margolis L; Balzarini J
    Cell Host Microbe; 2011 Oct; 10(4):379-89. PubMed ID: 22018238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
    Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
    Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines.
    De Clercq E; Andrei G; Balzarini J; Leyssen P; Naesens L; Neyts J; Pannecouque C; Snoeck R; Ying C; Hocková D; Holý A
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):331-41. PubMed ID: 16247948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2.
    Vanpouille C; Lisco A; Derudas M; Saba E; Grivel JC; Brichacek B; Scrimieri F; Schinazi R; Schols D; McGuigan C; Balzarini J; Margolis L
    J Infect Dis; 2010 Feb; 201(4):635-43. PubMed ID: 20085496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Drugs to Treat Infections with Herpes Simplex Viruses-1 and -2.
    Sadowski LA; Upadhyay R; Greeley ZW; Margulies BJ
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34202050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-carboxynucleoside phosphonates: direct-acting inhibitors of viral DNA polymerases.
    Balzarini J; Ford A; Maguire NM; John J; Das K; Arnold E; Dehaen W; Maguire A
    Future Med Chem; 2019 Jan; 11(2):137-154. PubMed ID: 30648904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-[2-phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines: a new class of acyclic pyrimidine nucleoside phosphonates with antiviral activity.
    Balzarini J; Pannecouque C; Naesens L; Andrei G; Snoeck R; De Clercq E; Hocková D; Holý A
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1321-7. PubMed ID: 15571252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro.
    Bourinbaiar AS; Coleman CF
    Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication.
    Luganini A; Sibille G; Mognetti B; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Gribaudo G
    Antiviral Res; 2021 May; 189():105057. PubMed ID: 33716051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral activity of PHA767491 against human herpes simplex virus in vitro and in vivo.
    Hou J; Zhang Z; Huang Q; Yan J; Zhang X; Yu X; Tan G; Zheng C; Xu F; He S
    BMC Infect Dis; 2017 Mar; 17(1):217. PubMed ID: 28320320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents.
    Thomsen DR; Oien NL; Hopkins TA; Knechtel ML; Brideau RJ; Wathen MW; Homa FL
    J Virol; 2003 Feb; 77(3):1868-76. PubMed ID: 12525621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues.
    Lisco A; Vanpouille C; Tchesnokov EP; Grivel JC; Biancotto A; Brichacek B; Elliott J; Fromentin E; Shattock R; Anton P; Gorelick R; Balzarini J; McGuigan C; Derudas M; Götte M; Schinazi RF; Margolis L
    Cell Host Microbe; 2008 Sep; 4(3):260-270. PubMed ID: 18779052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acyclic 2,4-diaminopyrimidine nucleoside phosphonate acts as a purine mimetic in HIV-1 reverse transcriptase DNA polymerization.
    Herman BD; Votruba I; Holy A; Sluis-Cremer N; Balzarini J
    J Biol Chem; 2010 Apr; 285(16):12101-8. PubMed ID: 20164190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and profiling of GS-9148, a novel nucleotide analog active against nucleoside-resistant variants of human immunodeficiency virus type 1, and its orally bioavailable phosphonoamidate prodrug, GS-9131.
    Cihlar T; Ray AS; Boojamra CG; Zhang L; Hui H; Laflamme G; Vela JE; Grant D; Chen J; Myrick F; White KL; Gao Y; Lin KY; Douglas JL; Parkin NT; Carey A; Pakdaman R; Mackman RL
    Antimicrob Agents Chemother; 2008 Feb; 52(2):655-65. PubMed ID: 18056282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity and intracellular metabolism of bis(tButylSATE) phosphotriester of beta-L-2',3'dideoxyadenosine, a potent inhibitor of HIV and HBV replication.
    Placidi L; Faraj A; Loi AG; Pierra C; Egron D; Cretton-Scott E; Gosseli G; Périgaud C; Martin LT; Schinazi RF; Imbach JL; el Kouni MH; Bryant ML; Sommadossi JP
    Antivir Chem Chemother; 2001 Mar; 12(2):99-108. PubMed ID: 11527047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.